Beyond Medical Technologies Inc.
Beyond Medical Technologies Inc. DOCT.CN Peers
See (DOCT.CN) competitors and their performances in Stock Market.
Peer Comparison Table: Industrial - Pollution & Treatment Controls Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
---|---|---|---|---|---|---|
DOCT.CN | CA$0.71 | -1.39% | 23.7M | 36.50 | CA$0.02 | N/A |
ACT.CN | CA$15.65 | -3.69% | 467.8M | -40.95 | -CA$0.39 | N/A |
GRN.TO | CA$0.10 | +0.00% | 16.5M | -10.50 | -CA$0.01 | N/A |
SHRC.CN | CA$0.08 | +0.00% | 12.2M | -2.50 | -CA$0.03 | N/A |
DST.CN | CA$0.07 | +0.00% | 4.2M | -0.54 | -CA$0.12 | N/A |
DELT.CN | CA$0.03 | -37.50% | 2.9M | -0.83 | -CA$0.03 | N/A |
ATMO.CN | CA$0.06 | -8.33% | 475.3K | -1.38 | -CA$0.04 | N/A |
Stock Comparison
DOCT.CN vs ACT.CN Comparison
DOCT.CN plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DOCT.CN stands at 23.7M. In comparison, ACT.CN has a market cap of 467.8M. Regarding current trading prices, DOCT.CN is priced at CA$0.71, while ACT.CN trades at CA$15.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DOCT.CN currently has a P/E ratio of 36.50, whereas ACT.CN's P/E ratio is -40.95. In terms of profitability, DOCT.CN's ROE is +0.46%, compared to ACT.CN's ROE of -0.99%. Regarding short-term risk, DOCT.CN is less volatile compared to ACT.CN. This indicates potentially lower risk in terms of short-term price fluctuations for DOCT.CN.